Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Inflammation01:38

Inflammation

Overview
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of survival in patients with pulmonary hypertension and acute right heart failure.

Bratislavske lekarske listy·2020
Same author

Rs6922269 marker at the MTHFD1L gene predict cardiovascular mortality in males after acute coronary syndrome.

Molecular biology reports·2015
Same author

Prediction of coronary vessel involvement on the basis of atherosclerosis risk factor analysis.

Bratislavske lekarske listy·2013
Same author

Association between a marker on chromosome 9 and acute coronary syndrome. confirmatory study on Czech population.

Folia biologica·2012
Same author

Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction and left ventricular dysfunction: a 24- month follow up study.

Bratislavske lekarske listy·2012
Same author

Genetic variants in haem oxygenase-1 and endothelial nitric oxide synthase influence the extent and evolution of coronary artery atherosclerosis.

Folia biologica·2011

Related Experiment Video

Updated: Jun 18, 2026

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

[Atherosclerosis in childhood].

M Aschermann1

  • 1II. interní klinika 1. LF UK a VFN, U Nemocnice 2, 128 08 Praha 2. michael.aschermann@vfn.cz

Casopis Lekaru Ceskych
|November 11, 2009
PubMed
Summary
This summary is machine-generated.

Atherosclerosis begins in childhood, necessitating early prevention strategies. Focusing on lifestyle factors like diet and exercise in children is crucial for long-term cardiovascular health.

Related Experiment Videos

Last Updated: Jun 18, 2026

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

Area of Science:

  • Cardiovascular Medicine
  • Pediatrics
  • Public Health

Context:

  • Atherosclerosis is a leading cause of mortality globally, with significant implications for adult health.
  • Atherosclerotic changes are detectable in childhood, particularly in offspring of mothers with hypercholesterolemia.
  • Early detection and intervention are critical for preventing long-term cardiovascular disease.

Purpose:

  • To summarize current knowledge on atherosclerosis in childhood.
  • To highlight the importance of primary prevention strategies targeting early atherosclerotic development.
  • To outline key areas for active prevention in pediatric populations.

Summary:

  • Atherosclerosis, a major contributor to adult mortality, originates in childhood.
  • Primary prevention efforts must commence early, addressing risk factors such as obesity, hypertension, and dyslipidemia.
  • Interventions should encompass lifestyle modifications including smoking cessation and management of metabolic syndrome.

Impact:

  • Establishes the foundation for lifelong cardiovascular health by intervening in childhood.
  • Reduces the future burden of atherosclerosis and its complications on healthcare systems.
  • Promotes a proactive approach to pediatric health, emphasizing preventative measures over treatment.